Technology

Discover scalable, instrument-free single cell sequencing technology from Parse Bioscience

Technology Overview


Resources

Explore our collection of resources to learn more about technology and its applications from leading researchers

Resources Overview

Company

Providing researchers single cell sequencing with unprecedented scale and ease

About Parse

Large-Scale Single Cell Services
GigaLab
10M+ Cells

For projects past the scale of a single kit. Send us your samples and we run the whole thing end to end, from barcoding through sequencing to analysis-ready data.

Parse Biosciences Parse Biosciences
LICENSABLE DATASET

Cascade

A large-scale RNA-seq and quantitative proteomics dataset of human immune response

NOMIC + PARSE BIOSCIENCES

Connect Cellular State to Immune Response Over Time

Cytokine and drug perturbations change cellular programs and the proteins released into the surrounding environment. These processes shape how immune responses develop within and between cells.

Yet most large-scale perturbation datasets focus on RNA at a single timepoint, leaving extracellular signaling and how it changes over time largely unmeasured.

Cascade brings these dimensions together, pairing Parse Biosciences’ single-cell transcriptomics with Nomic’s absolute quantitative secretome proteomics across donors, experimental conditions, and three timepoints.

11,500+
12M+
100M

Inside Cascade

The study was designed to provide breadth and depth across immune signaling pathways and cell types. Perturbations spanned diverse classes of immunomodulatory agents, including cytokines, chemokines, small molecules, and T cell and innate immune activators.

A Richer View of Immune Response

Perturbation Response

Cytokine and drug perturbations trigger biological responses across multiple molecular layers—from changes in cellular state to extracellular protein responses.

The Secretome

Immune cells release cytokines and other proteins into their environment that direct how they communicate, interact, and respond to intervention. Directly measuring the secretome reveals an important dimension of biology that is highly complimentary to intracellular RNA measurements.

Multimodal Discovery

Combining single-cell transcriptomics with absolute quantification of the secretome connects changes in cellular state with extracellular protein responses—providing a richer experimental foundation for understanding immune biology, drug target discovery, and predictive AI modeling.

One Dataset. Multiple Paths to Discovery.

Investigate immune biology, discover drug targets, and build predictive models with Cascade.

Cascade provides a matched view of cellular state and quantitative secretome response across donors, perturbations, and time—a unique experimental resource for exploring human immune biology.

AI Model Development

Develop and evaluate predictive models of immune response using matched transcriptomic and quantitative secretome measurements.

Target Identification

Explore immune signaling pathways and identify potential drug targets by connecting changes in cellular state with extracellular protein responses.

Drug Development

Investigate drug responses and mechanisms of action using a foundational reference of human immune biology

Extend Cascade

A Foundational Dataset to Build Upon

Cascade provides a foundational reference for human immune response. Nomic’s high-throughput, quantitative secretome proteomics can extend this measurement layer into disease-relevant samples, new perturbations, and additional experimental systems.

These studies can reveal how cytokines, drugs, and other perturbations alter extracellular signaling, identify pathways and potential targets associated with those responses, and compare response patterns across conditions at scale, bringing the biological framework established by Cascade into specific discovery programs.

Bring a Richer View of
Immune Response to Your Research

The Cascade dataset is being made available through a data partnership license. Cascade has already attracted foundational partners across biopharma and computational drug discovery. Parse and Nomic continue to welcome additional partners, with licensing available to launch partners through December 11 and to general partners afterward.
Contact Me About Cascade
English